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Usefulness of artificial neural networks to predict follow-up
dietary protein intake in hemodialysis patients.
Background. Artificial neural networks (ANN) represent a
promising alternative to classical statistical and mathematic
methods to solve multidimensional nonlinear problems. The
aim of the study was to verify, by comparing the perfor-
mance of ANN with that of experienced nephrologists, whether
ANN are useful tools in hemodialysis to predict the follow-up
(=1 month after the observation used for the prediction) di-
etary protein intake (PCR), and whether their performance is
influenced by the size of the population and by the data pool
used to built the model.
Methods. A combined retrospective and prospective obser-
vational study was performed in two Swiss dialysis units (84
chronic hemodialysis patients, 500 monthly clinical observa-
tions and biochemical test results). Using mathematical models
based on linear regressions to evaluate the variables, ANN were
built and then prospectively and interinstitutionally compared
with the ability of six experienced nephrologists to predict the
follow-up PCR.
Results. ANN compared with nephrologists gave a more ac-
curate correlation between estimated and calculated follow-up
PCR (P < 0.001). The same superiority of ANN was also seen in
the ability to detect a follow-up PCR <1.00 g/kg/day expressed
as a percentage of correct predictions, sensitivity, specificity, and
predictivity. The interinstitutional performance of the ANN is
positively influenced by the size and the variability of the pop-
ulation used to build the mathematical model.
Conclusion. The use of ANN significantly improves the abil-
ity of the experienced nephrologist to estimate and to detect
an unsatisfactory (<1.00 g/kg/day) follow-up PCR. The size
of the population selected to build the ANN is critical for his
performance.
The protein catabolic rate (PCR), determined by mea-
suring the interdialytic appearance of urea, is widely used
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in hemodialysis to assess the dietary protein intake. Even
if the plasma concentration of albumin, creatinine, urea,
and transferrin correlates with the nutritional status and
with the mortality risk [1], only PCR is of value in prospec-
tively predicting morbidity (significantly decreased by pa-
tients with a PCR >1 g/kg/day) [2]. For this reason a PCR
between 1.0 and 1.2 g/kg/day is currently recommended
[3]. The prediction of the evolution of the PCR, and
consequently, the detection of patients at risk of having,
in future assessments, unsatisfactory nutritional parame-
ters, is an important task that has until now been left to
the intuition and experience of the nephrologist. A large
amount of clinical and biochemical historical data of the
individual patients could be useful in making follow-up
decisions, but their interpretation, even using statisti-
cal models as multivariate linear regressions, is difficult.
The limits presented by the statistical procedures and by
the experience/intuition of the nephrologists are in part
caused by the nonlinearity of the multidimensional prob-
lems analyzed.
In many fields of clinical medicine, artificial neural
networks (ANN) have been successfully used to solve
complex and chaotic problems without the need of math-
ematical models and a precise understanding of the
mechanisms involved [4–6]. Some examples of artifi-
cial intelligence application of particular interest for
nephrologists are pharmacodynamics analysis [7–9] (e.g.,
cyclosporine dosage adjustment [10], heparin pharma-
cokinetics during hemodialysis [11]), time-course and di-
agnosis of chronic nephropathies (e.g., IgA nephropathy
[12], glomerular vs. tubular renal disease [13]), allograft
tolerance and function (chronic and acute allograft re-
jection [14–17]), diagnosis of renal transplant rejection
[18], prediction of cytomegalovirus disease after renal
transplantation [19], stratification of cardiac risk in renal
transplantation [20], and hemodialysis efficiency evalua-
tion (urea kinetic modeling [21, 22]). However, the nec-
essary quality criteria to build ANN [6] are not always
respected (insufficient variability of the data and lack of
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Table 1. Characteristics of the studied populations, hemodialysis prescriptions, and results of the monthly biochemical parameters in the
experimental and control groups of the two dialysis units
Control group Control group p DU1 Experimental Experimental p DU1
DU1 DU2 versus DU2 group DU1 group DU2 versus DU2
control experimental
Mean SD Mean SD group Mean SD Mean SD group
Age years 64 14 69 13 <0.001 69 13 64 12 n.s.
Dry weight kg 70 8 70 8 n.s. 69 8 74 15 n.s.
Body mass index kg/m2 25 3 26 5 n.s. 25 3 26 5 n.s.
Net ultrafiltration mL 1800 970 2210 1020 <0.001 1400 1040 2700 900 <0.001
Hemodialysis 3.17 0.37 3.70 0.34 <0.001 3.06 0.28 3.83 0.23 <0.001
duration hours
Dialyzer effective 1.8 0.2 1.8 0.2 n.s. 1.8 0.3 2.0 0.3 <0.001
surface area m2
KoA (mass area coefficient) 1258 74 1259 81 n.s. 1239 95 1299 45 <0.01
urea mL/min
Effective blood flow 323 55 319 71 n.s. 302 62 325 55 n.s.
mL/min
Dialysis fluid sodium 139 1 138 0 <0.001 139 1 139 2 n.s.
mmol/L
Dialysis fluid potassium 2.4 0.7 2.1 0.5 <0.001 2.5 0.7 2.0 0.4 <0.01
mmol/L
Dialysis fluid calcium 6.08 0.72 5.80 0.96 <0.001 5.88 0.72 5.48 0.88 n.s.
mg/dL
Dialysis fluid bicarbonate 31 1 32 0 <0.001 31 1 32 0 <0.01
mmol/L
Predialysis creatinine 8.57 2.81 7.12 1.92 <0.001 7.86 2.48 7.64 2.06 n.s.
mg/dL
Postdialysis creatinine 3.22 0.89 2.92 0.86 <0.001 3.09 0.91 3.18 0.83 n.s.
mg/dL
Predialysis BUN mg/dL 70.8 16.3 66.0 15.5 n.s. 63.4 16.1 68.8 20.3 n.s.
Postdialysis BUN mg/dL 20.9 6.8 19.7 7.1 n.s. 19.5 6.8 21.4 9.9 n.s.
Predialysis potassium 5.1 0.7 5.0 0.8 <0.001 5.1 0.6 5.4 0.8 0.05
mmol/L
Postdialysis potassium 3.7 0.4 3.5 0.4 <0.001 3.8 0.4 3.6 0.4 n.s.
mmol/L
Predialysis phosphate 5.42 1.39 5.15 1.70 n.s. 4.90 1.98 5.05 1.08 n.s.
mg/dL
Predialysis ionized calcium 4.68 0.40 4.88 0.32 <0.001 4.60 0.40 5.08 0.24 <0.001
mg/dL
Predialysis pH 7.39 0.05 7.35 0.05 <0.001 7.37 0.05 7.35 0.04 n.s.
Predialysis hematocrit % 34.3 3.2 34.4 3.4 n.s. 34.8 4.0 35.5 3.1 n.s.
Predialysis albumin g/dL 3.64 0.3 3.72 0.3 <0.01 3.55 0.4 3.82 0.3 <0.01
control group), and the interinstitutional variation in the
performance of these mathematical models has seldom
been analyzed in clinical fields [15].
We decided to investigate the ability of an artificial
intelligence software based on ANN compared with ex-
perienced nephrologists to predict the follow-up PCR in
a group of chronic hemodialysis patients, and to analyze
the interinstitutional variability in its performance.
The aim of the study was to verify whether mathemat-
ical models based on ANN are useful tools in the daily
clinical practice to predict the follow-up dietary protein
intake, and whether they may be prospectively applied to
patients from an independent institution.
METHODS
Two random samples of chronic hemodialysis patients
were selected from two independent Swiss dialysis units
(Ospedale La Carita`, Locarno and Ospedale Regionale
di Lugano, Lugano) in order to retrospectively collect the
monthly clinical, biochemical, and anthropometric pa-
rameters, and to calculate the normalized PCR. In order
to estimate the evolution of the protein intake, a sup-
plementary column listing the PCR value of one month
after the preceding PCR (follow-up PCR) was added to
the data table summarizing the results. With the inten-
tion of identifying, on the basis of a classical statistical
method, the data influencing the follow-up PCR (depen-
dent variable) and to build a mathematical estimation
model, a linear regression was performed. Furthermore,
with the aim of building nonlinear continuous functions
exploring and expressing the interdependency between
the collected data and the follow-up PCR, a series of
ANN were trained until they were successfully tested.
Finally, we selected, in a prospective way, two other
chronic hemodialysis patient groups from the same two
independent dialysis centers in order to test the selected
ANN, to evaluate the interinstitutional variation in their
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Fig. 1. Schematic representation of the artifi-
cial neural network used to predict the follow-
up protein catabolic rate (PCR): 6 + 1a input
variables, 10 + 1a hidden neurons, 81 connec-
tions (a = threshold node and neuron added
to avoid a zero output in the following layer).
performance, and to compare the obtained predictions
with those of six experienced nephrologists of the same
geographic region (three from center 2, and 3 from two
independent dialysis units).
Patients and laboratory tests
From the two dialysis centers (1 and 2) we selected two
random samples of chronic hemodialysis patients (older
than 17 years) treated for more than six months and with-
out intercurrent illnesses at the moment of enrolment as
control and experimental groups. The control groups con-
sisted of 20 and 44 patients from centers 1 and 2, respec-
tively (220 biochemical and clinical monthly data each
group), whereas there were 10 patients in both experi-
mental groups (30 biochemical and clinical monthly data
each group). The male/female ratio in the 4 groups was
1. For the characteristics of the studied populations see
Table 1.
The hemodialysis sessions were performed in both
dialysis units using a 4008 H bicarbonate-bag machine
and a high flux polysulfone membrane, both from Fre-
senius Medical Care (Stams, Switzerland). The dialysis
fluid temperature (36.5◦C) and flow rate (600 mL/min),
and the dialysis fluid concentrations for magnesium (0.5
mmol/L), acetate (3 mmol/L) and glucose (1 g/L) were
identical in the 4 groups. For the remaining hemodialysis
prescriptions see Table 1.
Calculation of Kt/V and protein catabolic rate
The Kt/V was calculated with a second-generation
single-pool Daugirdas formula [23]:
kt/V = −ln(R − 0.03) + [(4 − 3.5 × R) × (UF/W)]
where R = postdialysis BUN/predialysis BUN, UF = net
ultrafiltration, and W = weight. The normalized PCR was
Table 2. Summary of the abbreviations recurrent in the Tables and
Figures
DU1 Dialysis unit 1
DU2 Dialysis unit 2
ANN Artificial neural networks
NEPH Nephrologists
ANN11 ANN built with the data of dialysis unit 1 and tested in
dialysis unit 1
ANN12 ANN built with the data of dialysis unit 1 and tested in
dialysis unit 2
ANN21 ANN built with the data of dialysis unit 2 and tested in
dialysis unit 1
ANN22 ANN built with the data of dialysis unit 2 and tested in
dialysis unit 2
ANNC1 ANN built with the combination of the data of the two
dialysis units and tested in dialysis unit 1
ANNC2 ANN built with the combination of the data of two
dialysis units and tested in dialysis unit 2
NEPH1 Predictions of the nephrologists for dialysis unit 1
NEPH2 Predictions of the nephrologists for dialysis unit 2
CRMSE Combined Root Mean Square Error
LA Limits of agreement
95% bias 95% confidence interval for the bias
95% lower 95% confidence interval for the lower limits of agreement
95% upper 95% confidence interval for the upper limits of agreement
n.s. Non significant
calculated with the Jindal and Goldstein formula [ab-
stract; Jindal KK et al, Semin Dial 1:82, 1998]:
PCR = 0.22 + [0.036
× (follow-up BUN – post-dialysis BUN)
× 24]/ID interval
where follow-up BUN = BUN at the beginning of the
second dialysis session of the week, postdialysis BUN =
BUN at the end of the first dialysis session of the week,
and ID interval = time interval between the two dialyses.
Artificial neural networks
Artificial neural networks are accepted mathematical
methods to translate complex multivariate nonlinear
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Fig. 2. Histograms showing the percentage of correct answers, the sen-
sitivity, the specificity, and the predictivity in the estimation of the
follow-up PCR (lower or higher than 1.00 g/kg/day) for the artificial
neural networks (ANN) and the nephrologists (NEPH), respectively.
(A) Tested in dialysis unit 1. (B) Tested in dialysis unit 2. (C) All tested
ANN versus all predictions of the nephrologists. See Table 6 for prob-
abilities referred to in (A to C).
relationships into continuous functions; according to
Kolmogorov’s theorem, paying attention to network
structure, any arbitrary continuous function expressing
the dependent variable on the basis of the input data may
be built. Artificial neural networks were created, trained
(back-propagation algorithm), and tested using the
BrainMaker Professional software (California Scientific
Software 3.75, Nevada City, CA, USA). On the basis of
a constant learning rate, the training tolerance and the
percentage of good facts to stop training were initially
set at .15 and 95%, respectively. According to the
recommendations of the software producer, to optimize
the performance of the network the number of hidden
layers was limited to one; this was built with a number
of neurons equal to the number of input nodes if ≥10,
or with 10 neurons for a number of input nodes <10
(default settings). Furthermore, to estimate the suitable
minimum and maximum numbers of hidden neurons,
the following two formulas were used: minimum num-
ber of hidden neurons = (number of facts/10)—input
nodes—output nodes; maximum number of hidden
neurons = (number of facts/2)—input nodes—output
nodes (guideline 2 of the BrainMaker Professional
reference manual). The number of connections was
then calculated as follows: [(input nodes + 1) × hidden
neurons] + [(hidden neurons + 1) × output nodes]
(Fig. 1). The 1 added optionally to both the input and
the hidden layers represents a threshold neuron; an
extra neuron which always fires at full strength, allowing
the neurons in the next layer to have a nonzero output
even if all inputs are zeros. A sigmoid transfer function
was chosen for each neuron. Five different ANN were
designed and trained until successfully tested (more
then 85% of correct answers with a tolerance of 20%). As
input nodes, the variables known to or supposed to in-
fluence the follow-up PCR (according to the day-to-day
clinical experience and the results of a linear regression)
have been used: predialysis serum phosphate, serum al-
bumin, net ultrafiltration, predialysis blood urea nitrogen
(BUN), dialysis dose (Kt/V), and PCR (6 input variables,
10 hidden neurons, 81 connections). The study was de-
signed according to the prescriptions of Cross et al [6].
Statistical and data analysis
Statistical and data analysis was performed using two
different statistical software packages (Systat 7.0 and
SPSS 11.0; SPSS, Inc., Chicago, IL, USA). Nonparametric
kernel density estimators (Systat 7.0) were used to show
the distribution of the relative error generated from the
estimation of follow-up PCR. The differences between
kernel curves were judged with a repeated-measure anal-
ysis of variance (ANOVA) and a post-hoc Bonferroni test
(Systat 7.0). Comparisons between the characteristics of
the studied populations, the hemodialysis prescriptions,
and the results of the monthly biochemical parameters
were done with a two-group Student t test (Systat 7.0).
In all cases a P less than or equal to 0.05 was con-
sidered statistically significant. Accuracy was expressed
by the Combined Root Mean Square Error (CRMSE),
calculated as the square root of [(mean difference in
estimate-observed)2 + (standard deviation of the dif-
ference)2]. Agreement between the predictions and the
basis data is expressed by “limits of agreement,” “95%
confidence interval for the bias,” and “95% confidence
interval for the lower and upper limits of agreement,” ac-
cording to Bland and Altman [24]. For follow-up PCR,
results were expressed using a cut-of of 1.00 g/kg/day to
define correct predictions, and consequently, sensitivity,
specificity, and predictivity of the ANN or nephrologist
estimations. The differences between these data were
judged with a two-sample Student t test (Systat 7.0).
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Table 3. Accuracy expressed by the Combined Root Mean Square Error (CRMSE) and agreement expressed by the “limits of agreement” (LA),
the “95% confidence interval for the bias” (95% bias), and the “95% confidence interval for the lower (95% lower) and upper (95% upper) limits
of agreement” in the estimation of follow-up PCR
ANN11 NEPH1 ANN21 ANNC1 ANN12 NEPH2 ANN22 ANNC2
Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD
Accuracy 0.16 0.01 0.21 0.05 0.19 0.01 0.15 0.01 0.20 0.01 0.20 0.04 0.18 0.01 0.16 0.00
LA −0.32 0.03 −0.34 0.09 −0.26 0.02 −0.21 0.02 −0.33 0.03 −0.30 0.09 −0.33 0.04 −0.31 0.02
0.32 0.01 0.47 0.10 0.41 0.01 0.32 0.02 0.44 0.02 0.44 0.09 0.39 0.02 0.33 0.02
95% bias −0.03 0.02 0.03 0.02 0.05 0.02 0.03 0.02 0.02 0.02 0.04 0.02 0.00 0.02 −0.02 0.02
0.03 0.02 0.10 0.03 0.11 0.02 0.08 0.02 0.09 0.02 0.10 0.02 0.06 0.01 0.04 0.02
95% lower −0.36 0.04 −0.40 0.10 −0.31 0.02 −0.25 0.02 −0.39 0.04 −0.35 0.11 −0.38 0.04 −0.36 0.02
−0.27 0.03 −0.28 0.07 −0.21 0.02 −0.17 0.02 −0.27 0.03 −0.24 0.08 −0.27 0.04 −0.26 0.02
95% upper 0.27 0.01 0.41 0.09 0.36 0.01 0.28 0.02 0.38 0.02 0.38 0.08 0.33 0.02 0.28 0.02
0.37 0.01 0.53 0.12 0.46 0.01 0.36 0.02 0.50 0.02 0.49 0.11 0.44 0.02 0.37 0.02
Table 4. Probabilities referring to the differences in results in Table 3
ANN21 ANNC1 NEPH1 ANN22 ANNC2 NEPH2
ANN11 ANN12
Accuracy <0.001 0.01 <0.05 Accuracy <0.01 <0.001 n.s.
LA <0.01 <0.001 n.s. LA n.s. n.s. n.s.
<0.001 n.s. 0.01 <0.01 <0.001 n.s.
95% bias <0.001 <0.001 <0.01 95% bias n.s. 0.01 n.s.
<0.001 <0.01 <0.001 <0.05 <0.01 n.s.
95% lower <0.01 <0.001 n.s. 95% lower n.s. n.s. n.s.
<0.01 <0.001 n.s. n.s. n.s. n.s.
95% upper <0.001 n.s. <0.01 95% upper <0.01 <0.001 n.s.
<0.001 n.s. 0.01 <0.01 <0.001 n.s.
ANN21 ANN22
Accuracy <0.001 n.s. Accuracy <0.01 n.s.
LA 0.001 <0.05 LA n.s. n.s.
<0.001 n.s. <0.001 n.s.
95% bias n.s. n.s. 95% bias <0.05 <0.01
<0.05 n.s. <0.01 0.001
95% lower <0.001 <0.05 95% lower n.s. n.s.
<0.01 <0.05 n.s. n.s.
95% upper <0.001 n.s. 95% upper <0.001 n.s.
<0.001 n.s. <0.001 n.s.
ANNC1 ANNC2
Accuracy <0.01 Accuracy n.s.
LA <0.01 LA n.s.
<0.01 <0.05
95% bias n.s. 95% bias <0.001
n.s. <0.001
95% lower <0.01 95% lower n.s.
<0.01 n.s.
95% upper <0.01 95% upper 0.01
<0.01 <0.05
Receiver-operating-characteristic (ROC) curves (SPSS
11.0) plotting the sensitivity against 1 minus the speci-
ficity were drawn and analyzed (areas under the curves
calculated by the trapezoidal nonparametric method and
95% confidence interval) to compare the ability of the
ANN with that of the nephrologists to detect a follow-up
PCR <1.00 g/kg/day. Values were presented as mean ±
standard deviations (SD).
Comparison with experienced nephrologists
Six nephrologists from three different Swiss dialysis
centers were shown the monthly clinical, biochemical,
and anthropometric data of the experimental groups, and
Table 5. Probabilities referring to the differences in results in Figure 3
ANN21 ANN22 ANNC1 ANNC2 NEPH1 NEPH2
ANN11 n.s. n.s. <0.001
ANN12 n.s. <0.01 n.s.
ANN21 <0.01 <0.05
ANN22 n.s. n.s.
ANNC1 <0.001
ANNC2 <0.01
they were asked to predict the follow-up PCR. The distri-
bution of the error in the prediction, the amount of cor-
rect answers, the sensitivity, the specificity, and the pre-
dictivity were then compared with the results obtained
with the selected ANN.
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Table 6. Probabilities referring to the differences in results in Figure 2
ANN21 ANNC1 NEPH1 NEPH ANN22 ANNC2 NEPH2
ANN11 ANN12
Correct answers n.s. n.s. <0.001 Correct answers n.s. n.s. n.s.
True positive n.s. n.s. <0.001 True positive <0.01 <0.01 0.05
False positive n.s. n.s. <0.001 False positive n.s. n.s. n.s.
False negative <0.05 n.s. <0.01 False negative n.s. n.s. n.s.
ANN21 ANN22
Correct answers n.s. <0.001 Correct answers 0.01 <0.05
True positive n.s. <0.001 True positive n.s. 0.001
False positive n.s. <0.001 False positive 0.01 0.05
False negative n.s. <0.01 False negative n.s. n.s.
ANNC1 ANNC2
Correct answers <0.001 Correct answers n.s.
True positive <0.001 True positive <0.001
False positive <0.001 False positive n.s.
False negative <0.01 False negative n.s.
ANN
Correct answers n.s.
True positive 0.001
False positive <0.05
False negative 0.001
RESULTS
The results of the monthly biochemical parameters in
the experimental and control groups are listed in Table 1
(recurrent abbreviations in the Tables and Figures are
summarized in Table 2). The results of the calculated
monthly dialysis quality and nutritional parameters for
the control and experimental groups selected from dialy-
sis unit 1 were, respectively: Kt/V 1.43±0.25 versus 1.38±
0.25 and PCR 1.16 ± 0.21 versus 1.07 ± 0.22 g/kg/day,
whereas for dialysis unit 2: Kt/V 1.44 ± 0.24 versus 1.43 ±
0.29 and PCR 1.10 ± 0.20 versus 1.13 ± 0.24 g/kg/day.
Figure 2A-C depicts graphically the distribution of the
absolute error in the estimation of follow-up PCR pre-
dicted by ANN and nephrologists in the two dialysis
units studied. The ANOVA of the absolute value of
the error for the curves represented in the three pan-
els reaches a significant level that is compatible with
the behavior of the curves. The differences between the
ANN curves and those obtained from the predictions of
the nephrologists are significant for dialysis unit 1 ac-
cording to a post-hoc Bonferroni test. In dialysis unit
2, only the difference between the ANN built with the
combination of the data of the two centers and the pre-
dictions of the nephrologists reaches a significance. A
trend towards a better performance of the ANN built
with the largest population sample is visible in Tables 3
and 7. ANN built with the combination of the data
pools of the two dialysis units reached the best perfor-
mance in both centers (probabilities are listed in Tables 4
and 8). Comparing the follow-up prediction of the
nephrologists: known versus unknown patients (i.e., from
their own center or not), the subgroup analysis showed
no significant differences in their prediction ability (data
not shown).
According to Bland and Altman, agreements between
the predictions and the basis data expressed by “limits
of agreement,” “95% confidence interval for the bias,”
and “95% confidence interval for the lower and upper
limits of agreement” are given in Table 3. These results
are concordant with the previous statistical analysis, and
confirm the overall reduction in the magnitude of the
error by the use of ANN and by the increase in the size
of the population used to build the model. Probabilities
are listed in Table 4.
Histograms showing the percentage of correct predic-
tions, sensitivity, specificity, and predictivity (= positive
predictive value) in the estimation of follow-up PCR
(lower or higher than 1.00 g/kg/day) for the ANN and
the nephrologists are presented in Figure 2, while the
absolute number of correct predictions, true and false-
positive, and false-negative in the same estimations are
listed in Table 7. Once again, the superiority of ANN over
the nephrologists is highlighted. Similar to the previous
paragraphs, the size of the population used to build the
ANN influences positively the prediction ability. Proba-
bilities are listed in Figure 3, Tables 5, 6, and 8.
Figure 4 shows the resulting ROC curves plotting
the sensitivity against 1 minus the specificity in the
prediction of a follow-up PCR lower or higher than
1.00 g/kg/day obtained from both ANN and nephrol-
ogists. To allow an evaluation of the ability of the
nephrologists to predict the follow-up PCR, a curve
obtained with the initial PCR, which in fact expresses
the absence of prediction ability, has been added to
the graph as a reference line. The ROC areas under
the curves and the 95% confidence interval for ANN,
nephrologists, and initial PCR were: 0.902 (0.881–0.923),
0.837 (0.810–0.863), and 0.791 (0.760–0.822), respectively.
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Fig. 3. Nonparametric kernel density estimator (analogous to a contin-
uous histogram that shows where the data are most concentrated in the
sample) showing the distribution of the absolute error in the estimation
of follow-up PCR. (A) Tested in dialysis unit 1. (B) Tested in dialysis
unit 2. (C) All tested ANN versus all predictions of the nephrologists.
See Table 5 for probabilities referred to in (A and B).
DISCUSSION
In hemodialysis, biochemical data determined at
monthly intervals, as well as clinical parameters
registered at each dialysis session, give important infor-
mation to optimize the dialysis treatment, to prescribe
medications, and to customize dietary prescriptions.
However, a relevant amount of information contained
in these data, which could be very useful for the treat-
ment of the patients, and for the continuing education of
the nephrologist himself, because of the complexity, non-
linearity, and multidimensionality of the correlations, is
systematically lost. The relevance of the amount of infor-
mation that could be used thanks to an adequate mathe-
matical model is clearly demonstrated from our results, in
which ANN can achieve a better prediction of follow-up
PCR than experienced nephrologists (see Fig. 3C for the
distribution of the absolute error in this estimation, and
Fig. 4 for the ROC curves). Even though the mean er-
ror in the estimation of follow-up PCR for ANN is larger
than the difference between mean errors of ANN ver-
sus nephrologists, the relevance of the difference in the
prediction ability is underlined by the larger standard de-
viation of the second distribution (Fig. 3C), suggesting a
more random estimation by nephrologists. The difficulty
of this task is highlighted by the lack of statistical differ-
ence between the ROC curve obtained with the initial
PCR (expressing no prediction ability) compared with
that of the nephrologists (Fig. 4). However, the trend to-
wards a larger area under the ROC curve comparing the
initial PCR with the prediction of the nephrologists (0.791
vs. 0.837) and the statistical significant, but quantitative,
analogous difference between ANN and nephrologists
(0.902 vs. 0.837) corroborates the importance of the clin-
ical experience.
Mathematical models based on usual statistics like lin-
ear regressions are disappointing when used to analyze
multidimensional nonlinear data, and do not permit
building a model which could be used in daily clini-
cal practice. Data multidimensionality and nonlinearity
are the typical application fields for artificial intelligence
and, in particular, for ANN. These programs have been
successfully utilized in various medical specialities,
and the number of published studies demonstrates
that the subject is in continuous rapid expansion
[7–22].
Our data permit us to show that the information con-
tained in the historical biochemical results and clinical
parameters of the patients could significantly improve
the ability of the nephrologists to predict the risk of
protein malnutrition; this means that our intuition, even
if supported by long experience and classic statistical
methods, misses out on an important part of the usu-
ally available information. ANN have been applied suc-
cessfully in independent dialysis units; the results of the
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Table 7. Ability to detect a PCR <1.00 g/kg/day expressed as correct answers, true and false positive, and false negative (N = 30)
ANN11 ANN12 ANN21 ANN22 ANNC1 ANNC2 NEPH1 NEPH2
Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD
Correct answers 23.6 1.5 25.8 1.6 23.2 1.0 27.2 0.5 23.6 1.3 26.2 0.4 17.2 1.3 24.4 2.2
True positive 10.6 1.5 5.6 0.8 9.5 1.3 7.5 0.6 10.4 0.9 7.0 0.0 4.6 1.1 4.2 1.1
False positive 2.0 0.0 0.8 0.8 1.2 0.5 1.2 0.5 1.8 0.4 1.8 0.4 2.4 1.1 0.8 1.3
False negative 4.4 1.5 3.4 0.9 5.5 1.3 1.5 0.6 4.6 0.9 2.0 0.0 10.4 1.1 4.8 1.1
Table 8. Probabilities referring to the differences in the results in Table 7
ANN21 ANN22 ANNC1 ANNC2 NEPH1 NEPH2
ANN11
Correct answers n.s. n.s. <0.001
True positive n.s. n.s. <0.001
False positive 0.01 n.s. n.s.
False negative n.s. n.s. <0.001
ANN12
Correct answers n.s. n.s. n.s.
True positive <0.01 <0.01 n.s.
False positive n.s. <0.05 n.s.
False negative <0.01 <0.01 n.s.
ANN21
Correct answers n.s. <0.001
True positive n.s. <0.001
False positive n.s. n.s.
False negative n.s. <0.001
ANN22
Correct answers 0.01 <0.05
True positive n.s. 0.001
False positive n.s. n.s.
False negative n.s. 0.001
ANNC1
Correct answers <0.001
True positive <0.001
False positive n.s.
False negative <0.001
ANNC2
Correct answers n.s.
True positive <0.001
False positive n.s.
False negative <0.001
interinstitutional analysis of performance show that their
ability to generalize (efficiency when tested in a group
with a different distribution of the data) is dependent on
the size of the population, and consequently on the vari-
ability of the data used to train the network. The fact
that, as shown in Table 6, ANN built with the data of
dialysis unit 2 (more patients but less biochemical and
clinical monthly data per patient compared to dialysis
unit 1) performed better than those built with the data
of dialysis unit 1, suggests that to ensure a good perfor-
mance of the trained network, variability is more impor-
tant than quantity of the data. For these reasons, even if
each nephrologist could build a useful model on the basis
of the historical data of his dialysis unit, the collabora-
tion with other centers increases the ability of the model
to generalize and guarantees a higher sensitivity and
predictivity.
CONCLUSION
Our data show that ANN can give a significant con-
tribution and be helpful tools in the clinical practice for
the nephrologist treating chronic hemodialysis patients.
The correct appreciation of the trend in the evolution of
the protein nutritional status is an important challenge in
which the nephrologist could be helped by an ANN ap-
proach, consequently, permitting the application of pro-
phylactic measures. The ability of the ANN to predict
was positively influenced by the variability of the data
pool used to build the mathematical model; this has been
indirectly demonstrated by the positive impact of (1) the
size of the population used to train the ANN, and (2) the
use of data from independent dialysis units.
Future studies will show in which way the ANN perfor-
mance could be further ameliorated by the application of
the method to the clinical course of a single patient.
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Fig. 4. Receiver-operating-characteristic (ROC) curves plotting the
sensitivity against 1 minus the specificity in the prediction of a follow-
up PCR lower or higher than 1.00 g/kg/day obtained from both ANN
and nephrologists (NEPH). To evaluate the prediction ability of the
nephrologists, a curve obtained with the initial PCR has been added
to the graph as a reference line (i.e., no prediction ability). A perfect
prediction ability (with 100% sensitivity and specificity) would include
a point at the top lefthand corner; on the contrary the curve for a predic-
tion modality with no discriminatory power would appear as a diagonal
line from the bottom left to the top right-hand corner. P values for the
difference between ANN and NEPH, ANN and initial PCR, NEPH
and initial PCR, are <0.001, <0.001 and n.s., respectively.
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